Professional
Added to YB: 2025-02-25
Pitch date: 2025-02-18
ROIV [bullish]
Roivant Sciences Ltd.
+159.13%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies.
Market Cap
$19.4B
Pitch Price
$10.62
Price Target
N/A
Dividend
N/A
EV/EBITDA
-12.54
P/E
-23.09
EV/Sales
1.2K
Sector
Biotechnology
Category
special_situation
Show full summary:
Tourlite Capital Portfolio Holding: Roivant Sciences Ltd.
ROIV: Attractive risk-reward. ROIV stub <$2/share excl. cash & IMVT stake. Arbutus stake + LNP litigation exposure potentially worth $4. Multiple upside catalysts. Still holding Arbutus shares.
Read full article (1 min)